Literature DB >> 26925434

An emerging question about putative cancer stem cells in established cell lines-are they true stem cells or a fluctuating cell phenotype?

Pranesh Gunjal1, Daniel Pedziwiatr1, Ahmed A Ismail1, Sham S Kakar1, Mariusz Z Ratajczak1.   

Abstract

It has been proposed that established cell lines contain populations of cancer stem cells (CSCs), which are responsible for expansion of these cell lines and their metastatic potential. To address this issue better, we employed a human ovarian cancer cell line, A2780, and sorted cells according to the postulated highly mestatatic cancer stem cell phenotype, CD24+CD44-, and the less-metastatic CD24-CD44+ and CD24-CD44- phenotypes. These cells were employed in chemotaxis assays in vitro to migrate in response to conditioned media harvested from bone marrow or liver cells damaged by irradiation and in in vivo assays to grow tumors after injection into immunodeficient mice. We also sorted single cells expressing all three phenotypes by FACS and expanded them to grow clones. We found that the CD24+CD44- cells are a highly migratory population compared with CD24-CD44+ and CD24-CD44- cells and were seeded in higher numbers in murine bone marrow and liver after intravenous injection. Most importantly, we observed that singly sorted cells efficiently expanded ex vivo into cell populations that represented all phenotypes of the parental cell line. Thus, our data indicate that cells expressing a certain set of markers, e.g., CD24, have at any given moment a higher potential to migrate and metastasize. However, cells that are CD24-negative, if expanded from a singly sorted cell, may give rise to cells containing all of the markers, including CD24. Based on this finding, we propose that the CSC phenotype in cell lines fluctuates with cell expansion.

Entities:  

Keywords:  CD24; CD44; Cancer stem cells; changing phenotype; chemotaxis; singly sorted cells

Year:  2015        PMID: 26925434      PMCID: PMC4767173          DOI: 10.14343/jcscr.2015.3e1004

Source DB:  PubMed          Journal:  J Cancer Stem Cell Res        ISSN: 2329-5872


  12 in total

1.  Is sphere assay useful for the identification of cancer initiating cells of the ovary?

Authors:  María José Martínez-Serrano; Miguel Caballero-Baños; Ramon Vilella; Laura Vidal; Jaume Pahisa; Sergio Martínez-Roman
Journal:  Int J Gynecol Cancer       Date:  2015-01       Impact factor: 3.437

2.  Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas.

Authors:  Qi-Zhi He; Xun-Zhen Luo; Kai Wang; Qian Zhou; Hong Ao; Yan Yang; Shu-Xia Li; Ying Li; Hui-Ting Zhu; Tony Duan
Journal:  Cell Physiol Biochem       Date:  2014-01-24

3.  Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.

Authors:  Ilona Kryczek; Suling Liu; Michael Roh; Linhua Vatan; Wojciech Szeliga; Shuang Wei; Mousumi Banerjee; Yujun Mao; Jan Kotarski; Max S Wicha; Rebecca Liu; Weiping Zou
Journal:  Int J Cancer       Date:  2011-04-08       Impact factor: 7.396

4.  Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line.

Authors:  M F Shi; J Jiao; W G Lu; F Ye; D Ma; Q G Dong; X Xie
Journal:  Cell Mol Life Sci       Date:  2010-06-12       Impact factor: 9.261

Review 5.  Breast cancer and cancer stem cells: a mini-review.

Authors:  Alzbeta Filipova; Martina Seifrtova; Jaroslav Mokry; Josef Dvorak; Martina Rezacova; Stanislav Filip; Daniel Diaz-Garcia
Journal:  Tumori       Date:  2014 Jul-Aug       Impact factor: 2.098

6.  CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.

Authors:  M-Q Gao; Y-P Choi; S Kang; J H Youn; N-H Cho
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

7.  Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy.

Authors:  Gabriela Schneider; Zachariah Payne Sellers; Ahmed Abdel-Latif; Andrew J Morris; Mariusz Z Ratajczak
Journal:  Mol Cancer Res       Date:  2014-07-17       Impact factor: 5.852

8.  CD24 and Nanog identify stem cells signature of ovarian epithelium and cysts that may develop to ovarian cancer.

Authors:  Letizia Schreiber; Calanit Raanan; Abraham Amsterdam
Journal:  Acta Histochem       Date:  2013-10-06       Impact factor: 2.479

9.  Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells.

Authors:  Sham S Kakar; Mariusz Z Ratajczak; Karen S Powell; Mana Moghadamfalahi; Donald M Miller; Surinder K Batra; Sanjay K Singh
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

10.  Induction of a tumor-metastasis-receptive microenvironment as an unwanted and underestimated side effect of treatment by chemotherapy or radiotherapy.

Authors:  Mariusz Z Ratajczak; Tomasz Jadczyk; Gabriela Schneider; Sham S Kakar; Magda Kucia
Journal:  J Ovarian Res       Date:  2013-12-27       Impact factor: 4.234

View more
  11 in total

Review 1.  Of Cytometry, Stem Cells and Fountain of Youth.

Authors:  Dariusz Galkowski; Mariusz Z Ratajczak; Janusz Kocki; Zbigniew Darzynkiewicz
Journal:  Stem Cell Rev Rep       Date:  2017-08       Impact factor: 5.739

2.  Targeting of Lung Cancer Stem Cell Self-Renewal Pathway by a Small Molecule Verrucarin J.

Authors:  Karen Udoh; Seema Parte; Kelsey Carter; Aaron Mack; Sham S Kakar
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

3.  Do Cancer Cell Lines Have Fixed or Fluctuating Stem Cell Phenotypes? - Studies with the NTera2 Cell Line.

Authors:  Zachariah P Sellers; Gabriela Schneider; Kamila Bujko; Malwina Suszynska; Daniel Pedziwiatr
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

4.  Ovarian Cancer Stem Cells: Unraveling a Germline Connection.

Authors:  Seema C Parte; Andrei Smolenkov; Surinder K Batra; Mariusz Z Ratajczak; Sham S Kakar
Journal:  Stem Cells Dev       Date:  2017-11-28       Impact factor: 3.272

5.  Circulating Adipose Fatty Acid Binding Protein Is a New Link Underlying Obesity-Associated Breast/Mammary Tumor Development.

Authors:  Jiaqing Hao; Yuwen Zhang; Xiaofang Yan; Fei Yan; Yanwen Sun; Jun Zeng; Sabine Waigel; Yanhui Yin; Mostafa M Fraig; Nejat K Egilmez; Jill Suttles; Maiying Kong; Shujun Liu; Margot P Cleary; Edward Sauter; Bing Li
Journal:  Cell Metab       Date:  2018-08-09       Impact factor: 27.287

Review 6.  Revisiting the role of lysophosphatidic acid in stem cell biology.

Authors:  Gábor Tigyi; Kuan-Hung Lin; Il Ho Jang; Sue Chin Lee
Journal:  Exp Biol Med (Maywood)       Date:  2021-05-26

Review 7.  Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.

Authors:  Junli Deng; Li Wang; Hongmin Chen; Jingli Hao; Jie Ni; Lei Chang; Wei Duan; Peter Graham; Yong Li
Journal:  Oncotarget       Date:  2016-08-23

8.  Plastic CD34 and CD38 expression in adult B-cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations.

Authors:  F Lang; B Wojcik; S Bothur; C Knecht; J H F Falkenburg; T Schroeder; H Serve; O G Ottmann; M A Rieger
Journal:  Leukemia       Date:  2016-11-02       Impact factor: 11.528

9.  Leukemia propagating cells in Philadelphia chromosome-positive ALL: a resistant phenotype with an adverse prognosis.

Authors:  Nadia El-Menshawy; Sherin M Abd-Aziz; Enas M Elkhamisy; Mohammed A Ebrahim
Journal:  Blood Res       Date:  2018-06-25

Review 10.  Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms.

Authors:  Mariusz Z Ratajczak; Kamila Bujko; Aaron Mack; Magda Kucia; Janina Ratajczak
Journal:  Leukemia       Date:  2018-10-30       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.